Condition Lookup

Metastatic Lung Disease

Symptoms:
chronic cough; shortness of breath; chest pain; fatigue; unintentional weight loss; hemoptysis (coughing up blood); wheezing

Root Cause:
Cancer that has spread (metastasized) to the lungs from other parts of the body, often through the bloodstream or lymphatic system.

How it's Diagnosed: videos
Imaging studies (chest X-ray, CT scan, PET scan), biopsy of lung tissue, bronchoscopy, and analysis of fluid (if pleural effusion is present).

Treatment:
Treatment focuses on palliative care and control of the primary cancer. Options include systemic chemotherapy, targeted therapies, immunotherapy, and sometimes localized radiation therapy.

Medications:
Common medications include systemic chemotherapy agents (e.g., paclitaxel , carboplatin ), targeted therapies (e.g., EGFR inhibitors like erlotinib or ALK inhibitors like crizotinib ), and immune checkpoint inhibitors (e.g., pembrolizumab , nivolumab ).

Prevalence: How common the health condition is within a specific population.
Approximately 20-40% of cancers metastasize to the lungs. Prevalence depends on the type of primary cancer (e.g., breast, colorectal, kidney, and melanoma are common sources).

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Primary cancers with high metastatic potential, advanced-stage cancer, genetic predispositions, and immune suppression.

Prognosis: The expected outcome or course of the condition over time.
Poor overall prognosis, as metastatic lung disease is often a late-stage finding; survival depends on the type and extent of primary cancer and response to therapy.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Respiratory failure, pleural effusion, significant pain, decreased quality of life, and complications from treatments such as infections or side effects of systemic therapy.

Malignant Pleural Effusion

Specialty: Pulmonology

Category: Neoplastic Conditions

Symptoms:
shortness of breath; chest pain; dry cough; fatigue; orthopnea (difficulty breathing while lying down); decreased exercise tolerance

Root Cause:
Accumulation of cancerous fluid in the pleural space (the area between the lungs and chest wall) due to malignancies, often from lung cancer, breast cancer, or lymphoma.

How it's Diagnosed: videos
Thoracentesis with fluid cytology, chest imaging (X-ray, CT scan), pleural biopsy if needed, and thoracoscopy in selected cases.

Treatment:
Treatment involves drainage of the effusion (thoracentesis, chest tube placement), pleurodesis, indwelling pleural catheter for symptom relief, and systemic therapy targeting the underlying malignancy.

Medications:
Medications to manage the condition may include chemotherapy (e.g., cisplatin , pemetrexed ), targeted agents (e.g., bevacizumab for VEGF inhibition), and corticosteroids to reduce inflammation.

Prevalence: How common the health condition is within a specific population.
Occurs in about 15% of cancer patients, most frequently associated with lung and breast cancers.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Advanced malignancy, particularly lung or breast cancer, lymphoma, or cancers with high pleural involvement.

Prognosis: The expected outcome or course of the condition over time.
Generally poor, with median survival ranging from 3 to 12 months depending on the underlying cancer and response to therapy.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Recurrence of effusion, infection, lung collapse (atelectasis), impaired quality of life, and progression of underlying cancer.

Thymomas

Specialty: Pulmonology

Category: Neoplastic Conditions

Sub-category: Mediastinal Tumors

Symptoms:
chest pain; persistent cough; shortness of breath; hoarseness; fatigue; weight loss; muscle weakness (in cases of associated myasthenia gravis)

Root Cause:
A tumor arising from the epithelial cells of the thymus gland, typically located in the anterior mediastinum.

How it's Diagnosed: videos
Diagnosis involves imaging studies such as chest X-rays, CT scans, or MRI, along with biopsy (needle biopsy or surgical biopsy) to confirm histology. Blood tests may be used to check for associated autoimmune conditions.

Treatment:
Treatment typically involves surgical removal of the tumor (thymectomy), with or without adjuvant radiation therapy or chemotherapy depending on the stage of the disease.

Medications:
Chemotherapy agents like cisplatin (a platinum-based chemotherapy) or cyclophosphamide (an alkylating agent) may be used for advanced or unresectable cases. Immunosuppressive medications like prednisone or mycophenolate mofetil may also be prescribed if associated with autoimmune complications.

Prevalence: How common the health condition is within a specific population.
Rare, accounting for approximately 0.2-1.5% of all malignancies; thymomas are more common in adults, particularly in their 40s to 60s.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Associated with autoimmune diseases such as myasthenia gravis, red cell aplasia, and hypogammaglobulinemia. No strong environmental or genetic risk factors have been identified.

Prognosis: The expected outcome or course of the condition over time.
Generally good if detected early and completely resected. Advanced stages may have a poorer prognosis, with a 5-year survival rate of approximately 50-90%, depending on stage and treatment.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Potential complications include metastasis, recurrence, superior vena cava syndrome, and autoimmune disorders such as myasthenia gravis, red cell aplasia, or systemic lupus erythematosus.

Lymphomas

Specialty: Pulmonology

Category: Neoplastic Conditions

Sub-category: Mediastinal Tumors (Primary or secondary involvement of the mediastinum)

Symptoms:
enlarged lymph nodes (in the chest or other areas); persistent cough; shortness of breath; chest pain; fever; night sweats; unexplained weight loss; fatigue

Root Cause:
Malignancies of the lymphatic system involving abnormal proliferation of lymphocytes, often in the lymph nodes or extranodal lymphatic tissues such as the thymus. Common types include Hodgkin lymphoma and non-Hodgkin lymphoma.

How it's Diagnosed: videos
Diagnosed through imaging (CT, PET scan, or MRI), lymph node biopsy, and laboratory tests such as blood counts and immunophenotyping. Bone marrow biopsy may also be performed for staging.

Treatment:
Treatment depends on the type and stage. It may include chemotherapy (e.g., R-CHOP regimen for non-Hodgkin lymphoma or ABVD for Hodgkin lymphoma), radiation therapy, targeted therapies like rituximab (monoclonal antibody), and stem cell transplantation in refractory or relapsed cases.

Medications:
Chemotherapy regimens include cyclophosphamide (alkylating agent), doxorubicin (anthracycline), vincristine (vinca alkaloid), and prednisone (corticosteroid). Targeted therapy such as rituximab (monoclonal antibody against CD20) or brentuximab vedotin (antibody-drug conjugate) may also be prescribed.

Prevalence: How common the health condition is within a specific population.
Hodgkin lymphoma represents about 10% of all lymphomas, while non-Hodgkin lymphoma is one of the most common cancers globally. Mediastinal involvement occurs in 60-80% of Hodgkin cases and in certain subtypes of non-Hodgkin lymphomas.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Family history, immunosuppressive conditions (e.g., HIV/AIDS), exposure to Epstein-Barr virus (for Hodgkin lymphoma), exposure to herbicides or pesticides, and prior chemotherapy or radiation.

Prognosis: The expected outcome or course of the condition over time.
Prognosis varies depending on type and stage. Hodgkin lymphoma has an overall 5-year survival rate of approximately 85-90%, while non-Hodgkin lymphoma varies widely from 40-90%, depending on subtype and stage.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Potential complications include organ infiltration, immune system dysfunction, infections, secondary malignancies (due to chemotherapy or radiation), and complications from treatment (e.g., cardiotoxicity, pulmonary fibrosis).